Arbutus Biopharma Corporation

View Arbutus Biopharma Corporation ABUS stock quote prices, financial information, real-time forecasts, and company news from CNN.

Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026

Arbutus Biopharma Corporation (NASDAQ:ABUS) is one of the best biotech penny stocks to buy in 2026. On March 23, Arbutus ...
Nasdaq

Arbutus Biopharma to Initiate Phase 2b Clinical Trial of Imdusiran for Chronic Hepatitis B in 2025 Following Promising Phase 2a Results

Arbutus Biopharma Corporation announced plans to initiate a Phase 2b clinical trial in the first half of 2025 after reporting promising results from its Phase 2a trial, where a significant functional ...

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Arbutus Biopharma Corporation (NASDAQ:ABUS) is one of the 10 Best Penny Stocks to Buy and Hold Under $5. On April 14, 2026, ...
Forbes

Roivant Makes $116 Million Investment In Arbutus, Backing Battle With Moderna

Roivant Sciences and Moderna Therapeutics, two of the most highly-funded and controversial companies in the biotechnology world, are headed for a collision course over medical technology. On Monday, ...
Nasdaq

Arbutus Announces Positive Preliminary Phase 1a/1b Clinical Trial Results for AB-729, a Proprietary GalNAc Delivered RNAi Compound in Development for People Living with Chronic ...

WARMINSTER, Pa., March 26, 2020 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced positive preliminary results ...